In the last trading session, 55837.0 Aptevo Therapeutics Inc (NASDAQ:APVO) shares changed hands as the company’s beta touched 5.07. With the company’s per share price
During the last session, Aptevo Therapeutics Inc (NASDAQ:APVO)’s traded shares were 6.46 million, with the beta value of the company hitting 5.01. At the end
During the recent session, Aptevo Therapeutics Inc (NASDAQ:APVO)’s traded shares were 4.2 million, with the beta value of the company hitting 5.01. At the last
In the latest trading session, 2.08 million Aptevo Therapeutics Inc (NASDAQ:APVO) shares changed hands as the company’s beta touched 5.00. With the company’s most recent
In last trading session, Aptevo Therapeutics Inc (NASDAQ:APVO) saw 1.63 million shares changing hands with its beta currently measuring 5.06. Company’s recent per share price
Aptevo Therapeutics Inc (NASDAQ:APVO) has a beta value of 5.05 and has seen 0.72 million shares traded in the recent trading session. The APVO stock
During the last session, Aptevo Therapeutics Inc (NASDAQ:APVO)’s traded shares were 1.59 million, with the beta value of the company hitting 5.05. At the end
During the last session, Aptevo Therapeutics Inc (NASDAQ:APVO)’s traded shares were 12.73 million, with the beta value of the company hitting 5.02. At the end
In today’s recent session, 0.44 million shares of the Aptevo Therapeutics Inc (NASDAQ:APVO) have been traded, and its beta is 5.02. Most recently the company’s
In the last trading session, 3.89 million Aptevo Therapeutics Inc (NASDAQ:APVO) shares changed hands as the company’s beta touched 5.02. With the company’s per share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
